Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Richner’s Rule: Consider Reimbursement Early In Technology Development

This article was originally published in The Gray Sheet

Executive Summary

Possible reimbursement obstacles must be addressed during the initial phases of a technology's conception, Boston Scientific's Randel Richner told attendees at the DeviceCon 2004 summit

You may also be interested in...

Medicare Law May Offer Opening To Improve Telemedicine Payments – Report

CMS' Council for Technology & Innovation could serve as a vehicle to boost the tepid reimbursement environment for device-related health information technology (HIT), according to a report

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts